Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease

HIGHLIGHTS

• who: Mohammad Qadura from the Aristotle University of Thessaloniki, Greece have published the article: Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease, in the Journal: (JOURNAL)
• what: In the discovery phase, the authors report that approximately 23% of patients with PAD were non-sensitive to their 81 mg aspirin.
• future: The addition of 2.5 mg rivaroxaban twice daily in addition to 81 mg aspirin daily may help to reduce the increased risk of cardiovascular events in patients non-sensitive to aspirin and further . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.